US Patent No: 7,344,705

Number of patents in Portfolio can not be more than 2000

Composition comprising low density microspheres

1 Status Updates

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Low density microspheres, methods for preparing same, and use of same as contrast agents are described. The microspheres have a void which contains a gas or the vapor of a volatile liquid selected from the group consisting of aliphatic hydrocarbons, chlorofluorocarbons, tetraalkyl silanes and perfluorocarbons.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
LANTHEUS MEDICAL IMAGING, INC.NEW YORK, NY69

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Unger, Evan C Tucson, AZ 154 8295

Cited Art Landscape

Patent Info (Count) # Cites Year
 
Other [Check patent profile for assignment information] (5)
4,822,534 Method of producing microspheres 101 1987
4,996,041 Method for introducing oxygen-17 into tissue for imaging in a magnetic resonance imaging system 107 1988
5,190,766 Method of controlling drug release by resonant sound wave 212 1991
5,315,998 Booster for therapy of diseases with ultrasound and pharmaceutical liquid composition containing the same 194 1992
5,339,814 Process for visualizing tissue metabolism using oxygen-17 54 1992
 
Minnesota Mining and Manufacturing Company (3)
5,785,950 Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of making and using them 26 1994
5,502,094 Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods for use 81 1995
5,567,765 Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods of use 96 1996
 
BERSTEIN, ROBERT L. (1)
4,663,161 Liposome methods and compositions 114 1985
 
BRACCO INTERNATIONAL B.V. (5)
5,711,933 Method of making polymeric gas or air filled microballoons for ultrasonic echography 120 1994
5,531,980 Stable microbubbles suspensions injectable into living organisms 113 1994
5,578,292 Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof 91 1995
5,567,414 Stable microbubbles suspensions injectable into living organisms 109 1995
5,643,553 Stable microbubbles suspensions injectable into living organisms 112 1995
 
MATSUMOTO YUSHI-SEIYAKU CO., LTD. (1)
4,582,756 Organic microballoon 46 1984
 
RAMOT AT TEL-AVIV UNIVERSITY LTD. (1)
5,135,000 Method of measuring regional tissue blood flow 111 1991
 
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION (1)
6,635,017 Method and apparatus combining diagnostic ultrasound with therapeutic ultrasound to enhance thrombolysis 97 2000
 
DIOR PARFUMS CHRISTIAN, A COMPANY OF FRANCE (1)
4,621,023 Method of homogenizing dispersions of hydrated lipidic lamellar phases and suspensions obtained by the said method 52 1983
 
Royal Appliance Mfg. Co. (1)
5,535,500 Method for manufacturing a bucket for a wet/dry vacuum cleaner 37 1995
 
SYNTEX (U.S.A.) INC. (1)
5,470,582 Controlled delivery of pharmaceuticals from preformed porous polymeric microparticles 107 1993
 
The United States of America as represented by the Department of Health and Human Services (1)
5,612,318 Control of gene expression by ionizing radiation 49 1994
 
Eli Lilly and Company (1)
4,331,654 Magnetically-localizable, biodegradable lipid microspheres 314 1980
 
HemaGen/PFC (3)
5,350,571 Emulsions of highly fluorinated organic compounds 89 1992
5,571,498 Emulsions of paramagnetic contrast agents for magnetic resonance imaging (MRI). 31 1994
5,635,539 Stable emulsions of highly fluorinated organic compounds 26 1996
 
Hoechst Aktiengesellschaft (1)
5,205,287 Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents 255 1992
 
NATIONAL RESEARCH DEVELOPMENT CORPORATION (1)
4,427,649 Pharmaceutical compositions 98 1981
 
AECI LIMITED (1)
4,790,891 Process for the production of a cartridged explosive with entrapped bubbles 85 1987
 
ELAN PHARMACEUTICALS, INC. (2)
4,981,692 Therapeutic treatment by intramammary infusion 97 1987
5,008,050 Extrusion technique for producing unilamellar vesicles 176 1989
 
BRACCO SUISSE SA (7)
5,271,928 Stable microbubbles suspensions injectable into living organisms 192 1991
5,310,540 Method for the preparation of stable suspensions of hollow gas-filled microspheres suitable for ultrasonic echography 146 1992
5,380,519 Stable microbubbles suspensions injectable into living organisms 209 1993
5,445,813 Stable microbubble suspensions as enhancement agents for ultrasound echography 119 1993
5,556,610 Gas mixtures useful as ultrasound contrast media, contrast agents containing the media and method 179 1994
5,686,060 Stable microbubble suspensions comprising saturated phospholipids for ultrasound echography 80 1995
6,258,378 Delivery of biologically active substance to target sites in the body of patients 84 1999
 
Research Development Foundation (1)
5,049,388 Small particle aerosol liposome and liposome-drug combinations for medical use 203 1989
 
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (1)
4,767,610 Method for detecting abnormal cell masses in animals 43 1984
 
L'OREAL (1)
5,593,680 New cosmetic or dermopharmaceutical compositions in the form of aqueous gels modified by the addition of expanded microspheres 97 1994
 
HEMAGEN/PFC, 655 MONTGOMERY STREET, SUITE 1710, SAN FRANCISCO, CA. 94111, A LIMITED PARTNERSHIP OF CA. (1)
5,171,755 Emulsions of highly fluorinated organic compounds 123 1988
 
THE UNIVERSITY OF BRITISH COLUMBIA (1)
5,283,255 Wavelength-specific cytotoxic agents 72 1992
 
The Board of Trustees of the University of Illinois (1)
5,858,399 Acoustically reflective liposomes and methods to make and use the same 47 1996
 
SCHLIEF, REINHARD (1)
5,195,520 Ultrasonic manometry process in a fluid by means of microbubbles 175 1991
 
NIPPON STEEL CORPORATION (1)
5,147,631 Porous inorganic ultrasound contrast agents 219 1991
 
SEQUUS PHARMACEUTICALS, INC. (2)
5,213,804 Solid tumor treatment method and composition 231 1991
5,620,689 Liposomes for treatment of B-cell and T-cell disorders 98 1995
 
Collaborative Research, Inc. (1)
4,342,826 Immunoassay products and methods 111 1981
 
CEREVAST THERAPEUTICS, INC. (6)
5,149,319 Methods for providing localized therapeutic heat to biological tissues and fluids 267 1990
5,558,092 Methods and apparatus for performing diagnostic and therapeutic ultrasound simultaneously 413 1995
5,770,222 Therapeutic drug delivery systems 227 1995
6,537,246 Oxygen delivery agents and uses for the same 63 1997
6,315,981 Gas filled microspheres as magnetic resonance imaging contrast agents 76 1999
6,444,660 Lipid soluble steroid prodrugs 15 2000
 
IMARX PHARMACEUTICAL (1)
6,461,586 Method of magnetic resonance focused surgical and therapeutic ultrasound 25 2000
 
BIOCOMPATIBLES UK LIMITED (1)
4,675,310 Liposome composition as gas transport agents 89 1985
 
STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF OREGON (1)
4,863,717 Methods for circumventing the problem of free radial reduction associated with the use of stable nitroxide free radicals as contrast agents for magnetic reasonance imaging 126 1986
 
ATTA (1)
4,985,550 Polyhydroxylated and highly fluorinated compounds, their preparation and their use as surfactants 90 1987
 
OLSON, CAMILLA (1)
5,433,204 Method of assessing placentation 169 1993
 
Carlton Medical Products Limited (1)
4,646,756 Ultra sound hyperthermia device 211 1983
 
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (1)
4,938,947 Aerosol composition for in vivo imaging 86 1988
 
BARNES-JEWISH HOSPITAL (2)
5,958,371 Site specific binding system, nuclear imaging compositions and methods 41 1997
5,989,520 Site specific binding system, imaging compositions and methods 34 1998
 
Linton Medical Services Limited (1)
4,428,924 Preparation for diagnostic radiology 69 1980
 
PQ CORPORATION (4)
4,420,442 Manufacturing process for hollow microspheres 114 1982
4,421,562 Manufacturing process for hollow microspheres 100 1983
4,549,892 Process for producing hollow, bilayered silicate microspheres 69 1983
4,540,629 Hollow microspheres with organosilicon-silicate walls 85 1984
 
NORTHWESTERN UNIVERSITY (1)
5,612,057 Acoustically reflective liposomes and methods to make and use same 55 1995
 
SILICON VALLEY BANK (1)
5,193,183 System for accessing design data of modeler subsystems by reference to partnership set and for dynamically correlating design data of modeler subsystems 42 1990
 
IMARX THERAPEUTICS, INC. (7)
5,209,720 Methods for providing localized therapeutic heat to biological tissues and fluids using gas filled liposomes 192 1991
5,358,702 Methoxylated gel particle contrast media for improved diagnostic imaging 79 1993
5,736,121 Stabilized homogenous suspensions as computed tomography contrast agents 33 1995
5,874,062 Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents 39 1995
5,997,898 Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery 27 1995
6,414,139 Silicon amphiphilic compounds and the use thereof 29 1996
6,143,276 Methods for delivering bioactive agents to regions of elevated temperatures 77 1997
 
CAVITATION-CONTROL TECHNOLOGY, INC. (2)
4,684,479 Surfactant mixtures, stable gas-in-liquid emulsions, and methods for the production of such emulsions from said mixtures 208 1985
5,215,680 Method for the production of medical-grade lipid-coated microbubbles, paramagnetic labeling of such microbubbles and therapeutic uses of microbubbles 328 1990
 
UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (1)
5,019,370 Biodegradable, low biological toxicity radiographic contrast medium and method of x-ray imaging 104 1989
 
SURFACTANT TECHNOLOGIES, INC. (2)
4,426,330 Synthetic phospholipid compounds 162 1981
4,534,899 Synthetic phospholipid compounds 193 1983
 
E. R. Squibb & Sons, Inc. (1)
4,830,858 Spray-drying method for preparing liposomes and products produced thereby 148 1985
 
ALKERMES PHARMA IRELAND LIMITED (1)
5,569,448 Sulfated nonionic block copolymer surfactants as stabilizer coatings for nanoparticle compositions 162 1995
 
AMERICAN BIOSCIENCE, INC. (1)
5,362,478 Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell 159 1993
 
CALFEE HALTER & GRISWOLD, LLP (1)
4,603,044 Hepatocyte Directed Vesicle delivery system 143 1984
 
WAYNE STATE UNIVERSITY (1)
5,045,304 Contras agent having an imaging agent coupled to viable granulocytes for use in magnetic resonance imaging of abscess and a method of preparing and using same 75 1988
 
THE REGENTS OF THE UNIVERSITY OF MICHIGAN (1)
4,689,986 Variable frequency gas-bubble-manipulating apparatus and method 152 1985
 
HAFSTRUND NYCOMED INNOVATION, AB (1)
4,984,573 Method of electron spin resonance enhanced magnetic resonance imaging 73 1988
 
THE CURATORS OF THE UNIVERSITY OF MISSOURI (1)
4,789,501 Glass microspheres 172 1984
 
PNC BANK, NATIONAL ASSOCIATION (1)
4,533,254 Apparatus for forming emulsions 289 1984
 
The Lubrizol Corporation (1)
4,728,578 Compositions containing basic metal salts and/or non-Newtonian colloidal disperse systems and vinyl aromatic containing polymers 93 1986
 
PFC THERAPEUTICS, LLC (8)
4,865,836 Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport 159 1986
4,919,895 Apparatus for oxygenation of liquid state dissolved oxygen-carrying formulation 87 1987
4,987,154 Biocompatible, stable and concentrated fluorocarbon emulsions for contrast enhancement and oxygen transport in internal animal use 139 1987
4,927,623 Dissolution of gas in a fluorocarbon liquid 169 1988
5,077,036 Biocompatible stable fluorocarbon emulsions for contrast enhancement and oxygen transport comprising 40-125% wt./volume fluorocarbon combined with a phospholipid 57 1990
4,993,415 Magnetic resonance imaging with perfluorocarbon hydrides 121 1990
5,344,930 Fluorine and phosphorous-containing amphiphilic molecules with surfactant properties 116 1993
5,679,459 Perfluorinated amphiphilic phosphorous compounds: liposomal compositions 56 1995
 
University of Massachusetts (2)
4,544,545 Liposomes containing modified cholesterol for organ targeting 470 1983
4,900,540 Lipisomes containing gas for ultrasound detection 254 1983
 
ALLIANCE PHARMACEUTICAL CORP. (2)
5,460,800 Labeled fluorocarbon compositions 38 1994
5,980,936 Multiple emulsions comprising a hydrophobic continuous phase 80 1997
 
LANCASTER GROUP GMBH (1)
5,686,102 Pharmacological composition for topical administration 80 1996
 
GORDON, DAVID, SKOKIE, ILLINOIS (2)
4,569,836 Cancer treatment by intracellular hyperthermia 97 1983
4,731,239 Method for enhancing NMR imaging; and diagnostic use 124 1986
 
BASF AKTIENGESELLSCHAFT (1)
4,972,002 Process for producing cellular plastics by the polyisocyanate polyaddition method by means of stable emulsions containing blowing agents, and such emulsions 94 1989
 
NOVARTIS AG (1)
4,863,740 Interleukin therapy 31 1988
 
ACUSPHERE, INC. (2)
5,425,366 Ultrasonic contrast agents for color Doppler imaging 260 1993
6,068,857 Microparticles containing active ingredients, agents containing these microparticles, their use for ultrasound-controlled release of active ingredients, as well as a process for their production 69 1996
 
LASERSONIX TECHNOLOGIES (1)
5,840,023 Optoacoustic imaging for medical diagnosis 243 1996
 
La Jolla Cancer Research Foundation (1)
5,672,585 Method and composition for treating thrombosis 59 1995
 
IMCOR PHARMACEUTICAL CO. (1)
5,496,535 Fluorocarbon contrast media for use with MRI and radiographic imaging 80 1991
 
HENKEL CORPORATION (1)
4,722,943 Composition and process for drying and expanding microspheres 67 1987
 
Liposome Technology, Inc. (4)
4,737,323 Liposome extrusion method 234 1986
4,781,871 High-concentration liposome processing method 130 1986
4,895,719 Method and apparatus for administering dehydrated liposomes by inhalation 308 1987
5,013,556 Liposomes with enhanced circulation time 669 1989
 
KABUSHIKI KAISHA TOSHIBA (2)
4,620,546 Ultrasound hyperthermia apparatus 205 1985
5,485,839 Method and apparatus for ultrasonic wave medical treatment using computed tomography 129 1994
 
TRANSON LLC A DELAWARE CORPORATION (2)
5,695,460 Enhancement of ultrasound thrombolysis 154 1995
6,682,502 Apparatus for emergency treatment of patients experiencing a thrombotic vascular occlusion 59 2001
 
SLF LIMITED PARTNERSHIP (3)
4,572,203 Contact agents for ultrasonic imaging 263 1983
4,718,433 Contrast agents for ultrasonic imaging 276 1985
4,774,958 Ultrasonic imaging agent and method of preparation 264 1987
 
TRANSAVE, INC. (1)
5,552,155 Fusogenic lipsomes and methods for making and using same 73 1994
 
CIBA CORNING DIAGNOSTICS CORP. (1)
4,933,121 Process for forming liposomes 91 1988
 
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (6)
5,567,415 Ultrasound contrast agents and methods for their manufacture and use 91 1994
5,560,364 Suspended ultra-sound induced microbubble cavitation imaging 153 1995
5,701,899 Perfluorobutane ultrasound contrast agent and methods for its manufacture and use 92 1995
5,648,098 Thrombolytic agents and methods of treatment for thrombosis 57 1995
5,849,727 Compositions and methods for altering the biodistribution of biological agents 59 1996
5,740,807 Suspended ultra-sound induced microbubble cavitation imaging 55 1996
 
LVMH RECHERCHE, A FRENCH CORP. (1)
5,198,225 Hydrated lipidic lamellar phases or liposomes based on ecdysteroids 83 1991
 
SIEMENS AKTIENGESELLSCHAFT (1)
4,334,929 Use of nickel-cobalt sintered materials for electric relay contacts 3 1980
 
WEST PHARMACEUTICAL SERVICES DRUG DELIVERY & CLINICAL RESEARCH CENTRE LIMITED (1)
5,648,095 Preparation of microparticles 121 1994
 
FUJITSU LIMITED (1)
5,539,814 Method and apparatus for informing active subscriber of disconnection of held subscriber in call-waiting service 23 1995
 
NanoScan Imaging LLC (1)
5,114,703 Percutaneous lymphography using particulate fluorocarbon emulsions 152 1990
 
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (1)
5,196,348 Perfluoro-crown ethers in fluorine magnetic resonance spectroscopy of biopsied tissue 62 1991
 
ABRAXIS BIOSCIENCE, LLC (5)
5,498,421 Composition useful for in vivo delivery of biologics and methods employing same 285 1994
5,508,021 Non-fluorinated polymeric shells for medical imaging 137 1994
5,505,932 Method for the preparation of fluorocarbon-containing polymeric shells for medical imaging 151 1995
5,512,268 Polymeric shells for medical imaging prepared from synthetic polymers, and methods for the use thereof 111 1995
5,639,473 Methods for the preparation of nucleic acids for in vivo delivery 121 1995
 
Takeda Chemical Industries, Ltd. (1)
4,877,561 Method of producing liposome 94 1987
 
BRISTOL-MYERS SQUIBB MEDICAL IMAGING, INC. (1)
6,416,740 Acoustically active drug delivery systems 148 1998
 
AMERSHAM HEALTH AS (1)
5,897,851 Nucleation and activation of a liquid-in-liquid emulsion for use in ultrasound imaging 33 1996
 
GE HEALTHCARE AS (22)
4,844,882 Concentrated stabilized microbubble-type ultrasonic imaging agent 251 1987
5,558,855 Phase shift colloids as ultrasound contrast agents 103 1993
5,393,524 Methods for selecting and using gases as ultrasound contrast media 169 1993
5,529,766 Contrast agents 103 1993
5,536,490 Contrast agents 117 1993
5,595,723 Method for preparing storage stable colloids 83 1993
5,558,853 Phase shift colloids as ultrasound contrast agents 146 1994
5,562,893 Gas-filled microspheres with fluorine-containing shells 89 1994
5,558,856 Microbubble-generating contrast agents for ultrasound and magnetic resonance imaging 147 1994
5,573,751 Persistent gaseous bubbles as ultrasound contrast media 80 1994
5,558,854 Ultrasound contrast media comprising perfluoropentane and perfluorohexane gas 105 1995
5,558,094 Methods for using persistent gases as ultrasound contrast media 98 1995
5,614,169 Contrast agents, consisting of galactose particles and an amphilic carboxylic acid 64 1995
5,567,413 Flexible amphiphilic microbubbles for ultrasound 100 1995
5,676,928 Liposomes 95 1995
5,707,606 Phase shift colloids as ultrasound contrast agents 56 1995
5,707,607 Phase shift colloids as ultrasound contrast agents 62 1995
5,976,501 Use of pressure resistant protein microspheres encapsulating gases as ultrasonic imaging agents for vascular perfusion 32 1996
6,331,289 Targeted diagnostic/therapeutic agents having more than one different vectors 72 1997
6,261,537 Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors 161 1997
6,159,445 Light imaging contrast agents 223 1997
6,680,047 Diagnostic/therapeutic agents 41 2001
 
The Penn State Research Foundation (1)
5,487,390 Gas-filled polymeric microbubbles for ultrasound imaging 153 1994
 
ISOTECHNIKA INC. (1)
5,846,514 Enhancement of the efficacy of nifedipine by deuteration 97 1996
 
ALZA CORPORATION (1)
4,344,929 Method of delivering drug with aid of effervescent activity generated in environment of use 121 1981
 
INSIGHTEC LTD. (1)
5,247,935 Magnetic resonance guided focussed ultrasound surgery 143 1992
 
DREWES, WILLIAM (1)
4,315,514 Method and apparatus for selective cell destruction 227 1980
 
THOMSON-CSF (1)
4,586,512 Device for localized heating of biological tissues 226 1985
 
NOVAVAX, INC. (2)
5,000,960 Protein coupling to lipid vesicles 101 1989
5,219,538 Gas and oxygen carrying lipid vesicles 89 1991
 
NYCOMED IMAGING AS (3)
5,196,183 Contrast agents for ultrasound imaging 115 1991
5,354,549 Iodinated esters 78 1991
5,569,449 Gaseous microparticles as ultrasound contrast agents 95 1995
 
CALIFORNIA INSTITUTE OF TECHNOLOGY (1)
4,310,506 Means of preparation and applications of liposomes containing high concentrations of entrapped ionic species 146 1980
 
SCHERING AKTIENGESELLSCHAFT (7)
4,442,843 Microbubble precursors and methods for their production and use 242 1981
4,466,442 Carrier liquid solutions for the production of gas microbubbles, preparation thereof, and use thereof as contrast medium for ultrasonic diagnostics 304 1982
4,657,756 Microbubble precursors and apparatus for their production and use 262 1983
4,681,119 Method of production and use of microbubble precursors 228 1986
4,918,065 Corticoid-containing preparation for topical application 56 1988
5,141,738 Ultrasonic contrast medium comprising gas bubbles and solid lipophilic surfactant-containing microparticles and use thereof 184 1991
5,501,863 Contrast media synthesized from polyaldehydes 121 1995
 
THE DOW CHEMICAL COMPANY (1)
4,485,193 Expandable synthetic resinous thermoplastic particles, method for the preparation thereof and the application therefor 48 1984
 
MASSACHUSETTS INSTITUTE OF TECHNOLOGY (4)
4,921,706 Unilamellar lipid vesicles and method for their formation 142 1984
4,898,734 Polymer composite for controlled release or membrane formation 209 1988
4,893,624 Diffuse focus ultrasound hyperthermia system 181 1988
5,565,215 Biodegradable injectable particles for imaging 153 1994
 
REINHARD SCHLIEF (1)
5,380,411 Ultrasound or shock wave work process and preparation for carrying out same 143 1990
 
TECHNOMED MEDICAL SYSTEMS, S.A. (1)
4,658,828 Apparatus for examining and localizing tumors using ultra sounds, comprising a device for localized hyperthermia treatment 167 1985
 
CEREVAST MEDICAL, INC. (2)
6,716,412 Methods of ultrasound treatment using gas or gaseous precursor-filled compositions 35 2001
6,576,220 Non-invasive methods for surgery in the vasculature 30 2001
 
Temple University (1)
5,562,608 Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation 239 1995
 
Patrinove (1)
5,194,188 Process and a device for the direct production of liposomes 20 1991
 
EXOGEN, INC. (2)
4,530,360 Method for healing bone fractures with ultrasound 202 1982
5,556,372 Apparatus for ultrasonic bone treatment 121 1995
 
DR. F. KOHLER CHEMIE GMBH (2)
5,137,928 Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents 180 1991
5,190,982 Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents 116 1992
 
MALLINCKRODT MEDICAL, INC. (1)
5,362,477 19F magnetic resonance imaging agents which include a nitroxide moiety 52 1992
 
Aktiebolaget Draco (1)
4,693,999 Liposomes containing steroid esters 74 1985
 
SUMMERS, DAVID (1)
5,186,922 Use of biodegradable microspheres labeled with imaging energy constrast materials 126 1990
 
Molecular Biosystems, Inc. (9)
4,957,656 Continuous sonication method for preparing protein encapsulated microbubbles 231 1988
5,107,842 Method of ultrasound imaging of the gastrointestinal tract 98 1991
5,315,997 Method of magnetic resonance imaging using diamagnetic contrast 136 1992
5,716,597 Emulsions as contrast agents and method of use 66 1993
5,552,133 Method of making encapsulated gas microspheres useful as an ultrasonic imaging agent 148 1994
5,536,489 Emulsions as contrast agents and method of use 150 1995
5,606,973 Liquid core microdroplets for ultrasound imaging 67 1995
5,732,707 Method of ultrasonically quantitating myocardial perfusion using as intravenously injected tracer 115 1996
5,855,865 Method for making encapsulated gas microspheres from heat denatured protein in the absence of oxygen gas 61 1997
 
ILLINOIS INSTITUTE OF TECHNOLOGY, A NOT-FOR-PROFIT CORP. OF ILLINOIS (1)
4,776,991 Scaled-up production of liposome-encapsulated hemoglobin 126 1986
 
CHILDREN'S HOSPITAL RESEARCH FOUNDATION (2)
4,775,522 NMR compositions for indirectly detecting a dissolved gas in an animal 117 1985
5,536,753 Stable perfluorocarbon and oil emulsions 19 1990
 
THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (1)
5,545,396 Magnetic resonance imaging using hyperpolarized noble gases 130 1994
 
NEXSTAR PHARMACEUTICALS, INC. (2)
4,728,575 Contrast agents for NMR imaging 123 1985
5,008,109 Vesicle stabilization 83 1988
 
DANA-FARBER CANCER INSTITUTE, INC. (1)
5,571,797 Method of inducing gene expression by ionizing radiation 53 1994
 
TARGESON, INC. (6)
5,605,673 Stabilized microbubble compositions for ultrasound 113 1994
5,540,909 Harmonic ultrasound imaging with microbubbles 148 1994
5,639,443 Stabilized microbubble compositions 116 1995
5,626,833 Ultrasound imaging method using microbubbles 71 1995
5,804,162 Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients 55 1995
5,733,527 Methods for harmonic imaging with ultrasound 66 1996
 
LIPSOME TECHNOLOGY, INC., A CORP. OF DE (1)
5,194,266 Amphotericin B/cholesterol sulfate composition and method 78 1991
 
EASTMAN KODAK COMPANY (1)
5,078,994 Microgel drug delivery system 100 1990
 
M.R.I., Inc. (1)
4,834,964 Use of charged nitroxides as NMR image enhancing agents for CSF 82 1986
 
AIR PRODUCTS AND CHEMICALS, INC. (2)
4,866,096 Stable fluorochemical aqueous emulsions 71 1987
4,895,876 Concentrated stable fluorochemical aqueous emulsions containing triglycerides 64 1987
 
LANTHEUS MEDICAL IMAGING, INC. (24)
5,088,499 Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same 219 1990
5,205,290 Low density microspheres and their use as contrast agents for computed tomography 122 1991
5,228,446 Gas filled liposomes and their use as ultrasonic contrast agents 98 1991
5,123,414 Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same 169 1991
5,230,882 Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same 108 1992
5,352,435 Ionophore containing liposomes for ultrasound imaging 123 1992
5,281,408 Low density microspheres and their use as contrast agents for computed tomography 171 1993
5,305,757 Gas filled liposomes and their use as ultrasonic contrast agents 97 1993
5,469,854 Methods of preparing gas-filled liposomes 240 1993
5,334,381 Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same 206 1993
5,456,900 Low density microspheres and their use as contrast agents for computed tomography 70 1993
5,542,935 Therapeutic delivery systems related applications 293 1993
5,585,112 Method of preparing gas and gaseous precursor-filled microspheres 224 1993
5,830,430 Cationic lipids and the use thereof 117 1995
5,547,656 Low density microspheres and their use as contrast agents for computed tomography, and in other applications 153 1995
5,527,521 Low density microspheres and suspensions and their use as contrast agents for computed tomography and in other applications 95 1995
6,146,657 Gas-filled lipid spheres for use in diagnostic and therapeutic applications 62 1996
5,846,517 Methods for diagnostic imaging using a renal contrast agent and a vasodilator 131 1997
6,528,039 Low density microspheres and their use as contrast agents for computed tomography and in other applications 41 1997
6,548,047 Thermal preactivation of gaseous precursor filled compositions 67 1997
6,231,834 Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same 100 1997
6,551,576 Container with multi-phase composition for use in diagnostic and therapeutic applications 61 1998
6,056,938 Cationic lipids and the use thereof 55 1998
6,479,034 Method of preparing gas and gaseous precursor-filled microspheres 35 1998
 
PHARES PHARMACEUTICAL RESEARCH, N.V. (1)
5,004,611 Pro-liposome compositions 97 1988
 
VANDERBILT UNIVERSITY (1)
4,615,879 Particulate NMR contrast agents for gastrointestinal application 139 1983
 
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (2)
5,192,549 Method of amphiphatic drug loading in liposomes by pH gradient 142 1989
5,316,771 Method of amphiphatic drug loading in liposomes by ammonium ion gradient 146 1992
 
DUPONT PHARMACEUTICALS COMPANY (2)
6,443,898 Therapeutic delivery systems 66 1995
6,521,211 Methods of imaging and treatment with targeted compositions 105 1999
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
DIXIE CONSUMER PRODUCTS LLC (1)
* 2010/0012,712 PAPER CUP MANUFACTURE WITH MICROENCAPSULATED ADHESIVE 2 2009
 
WELLS FARGO BANK, NATIONAL ASSOCIATION (2)
8,685,441 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend 1 2013
8,747,892 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend 1 2013
 
LANTHEUS MEDICAL IMAGING, INC. (4)
8,084,056 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend 3 2003
* 2004/0057,991 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend 11 2003
8,658,205 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend 1 2011
9,545,457 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend 0 2014
 
GEORGIA-PACIFIC CHEMICALS LLC (2)
9,163,169 Adhesive compositions having a reduced cure time and methods for making and using same 0 2013
8,674,019 Composite products made with lewis acid catalyzed binder compositions that include tannins and multifunctional aldehydes 0 2013
* Cited By Examiner

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 18, 2019
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00